Pediatric drug hypersensitivity: which diagnostic tests?
- PMID: 30830067
- PMCID: PMC6502170
- DOI: 10.23750/abm.v90i3-S.8171
Pediatric drug hypersensitivity: which diagnostic tests?
Abstract
Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children.
References
-
- Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016;71:149–161. - PubMed
-
- Foong RX, Logan K, Perkin MR, du Toit G. Lack of uniformity in the investigation and management of suspected beta-lactam allergy in children. Pediatr Allergy Immunol. 2016;27:527–32. - PubMed
-
- Rebelo GE, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38:191–198. - PubMed
-
- Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008;19:634–638. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
